Electromed reports Q3 EPS 21c vs 17c last year

Reports Q3 revenue $15.7M, two estimates $15.75M. “I am pleased to report our tenth consecutive quarter of year-over-year revenue and net income growth,” said Jim Cunniff, Electromed (ELMD) President and Chief Executive Officer. “In addition to our excellent operational performance, we advanced multiple market development initiatives designed to highlight the value of SmartVest Clearway therapy to both healthcare professionals and patients, including the launch of a Veterans Administration direct-to-consumer outreach program in 11 cities. I am proud of the Electromed team’s results, as well as our position as a growing and profitable small-cap medical technology company with a consistent track record of value creation for our shareholders.”